Does Abeona Therapeutics Inc (NASDAQ:ABEO) Look Expensive At $6.20? Here’s How To Know.

In last trading session, Abeona Therapeutics Inc (NASDAQ:ABEO) saw 0.83 million shares changing hands with its beta currently measuring 1.35. Company’s recent per share price level of $6.20 trading at $0.92 or 17.42% at ring of the bell on the day assigns it a market valuation of $153.57M. That closing price of ABEO’s stock is at a premium of 4.19% from its 52-week high price of $5.94 and is indicating a premium of 64.68% from its 52-week low price of $2.19. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.35 million shares which gives us an average trading volume of 231.59K if we extend that period to 3-months.

Abeona Therapeutics Inc (NASDAQ:ABEO) trade information

Upright in the green during last session for gaining 17.42%, in the last five days ABEO remained trading in the green while hitting it’s week-highest on Friday, 02/09/24 when the stock touched $6.20 price level, adding 2.05% to its value on the day. Abeona Therapeutics Inc’s shares saw a change of 23.75% in year-to-date performance and have moved 40.27% in past 5-day. Abeona Therapeutics Inc (NASDAQ:ABEO) showed a performance of 15.03% in past 30-days. Number of shares sold short was 0.66 million shares which calculate 2.78 days to cover the short interests.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

Abeona Therapeutics Inc (ABEO) estimates and forecasts

Statistics highlight that Abeona Therapeutics Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company added 107.36% of value to its shares in past 6 months, showing an annual growth rate of 54.47% while that of industry is 15.80. Apart from that, the company came raising its revenue forecast for fiscal year 2024.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 19.64% during past 5 years.

ABEO Dividends

Abeona Therapeutics Inc is more likely to be releasing its next quarterly report between March 27 and April 01 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.

Abeona Therapeutics Inc (NASDAQ:ABEO)’s Major holders

Insiders are in possession of 5.67% of company’s total shares while institution are holding 52.38 percent of that, with stock having share float percentage of 55.53%. Investors also watch the number of corporate investors in a company very closely, which is 52.38% institutions for Abeona Therapeutics Inc that are currently holding shares of the company. Adage Capital Partners GP L.L.C. is the top institutional holder at ABEO for having 1.76 million shares of worth $7.1 million. And as of Jun 29, 2023, it was holding 7.11% of the company’s outstanding shares.

The second largest institutional holder is Nantahala Capital Management, LLC, which was holding about 1.4 million shares on Jun 29, 2023. The number of shares represents firm’s hold over 5.66% of outstanding shares, having a total worth of $5.65 million.

On the other hand, Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Jun 29, 2023, the former fund manager was holding 0.41 million shares of worth $1.65 million or 1.66% of the total outstanding shares. The later fund manager was in possession of 0.2 million shares on Jun 29, 2023, making its stake of worth around $0.82 million in the company or a holder of 0.82% of company’s stock.

On Key

Related Posts